Tehran University of Medical Sciences Faculty Member Receives World Health Organization Award

Dr. Amirali Hamidieh, faculty member at Tehran University of Medical Sciences, received the World Health Organization award in recognition of years of pioneering efforts in developing childhood cancer treatment and hematopoietic stem cell transplantation.

In recognition of efforts in the treatment of children's cancer;

Dr. Amir Ali Hamidieh, a faculty member of Tehran University of Medical Sciences, received the World Health Organization award for his years of pioneering efforts in the development of pediatric cancer treatment and hematopoietic stem cell transplantation.

According to Ambassador Arjan's report, quoted from Tehran University of Medical Sciences, in an event of honor for the scientific and medical community of Iran, Dr. Amir Ali Hamidieh, a faculty member of Tehran University of Medical Sciences, received the World Health Organization Award for Cancer Control from Dr. Tedros Adhanom, Director General of the World Health Organization, in recognition of his years of pioneering efforts in the development of pediatric cancer treatment and hematopoietic stem cell transplantation. An international honor that once again demonstrated the ability of Iranian scientists and the position of Tehran University of Medical Sciences in advancing the frontiers of medical knowledge and developing justice in health.

At the meeting of the ministers of health of the countries of the Eastern Mediterranean region of the World Health Organization, which was held on October 13, 2026 (October 21, 1405) in Cairo, the location of the Eastern Mediterranean regional office of the World Health Organization, Dr. Amir Ali Hamidieh, a professor at Tehran University of Medical Sciences and one of the prominent figures in the field of hematopoietic stem cell transplantation and childhood cancer treatment, received the "World Health Organization Award for Cancer Control".

Dr. Tedros Adhanom, Director General of the World Health Organization presented this award to this outstanding professor of Tehran University of Medical Sciences in the presence of high-ranking health officials of the region.

This international success is a manifestation of the scientific role of Tehran University of Medical Sciences in the development of advanced treatments, the expansion of fair access to specialized services, and the promotion of Iran's medical status in the regional and global arena.

From establishing the first child transplant center to saving the lives of more than 2,200 children

Hamidieh, who is one of the pioneers in the development of pediatric hematopoietic stem cell transplantation in Iran, in his speech, referring to the establishment of the first pediatric hematopoietic stem cell transplant center in the country in 2007, announced that this treatment program has given more than 2,200 children a chance to survive.

He also considered the launch of the first non-relative donor registration system in the Eastern Mediterranean region in 2009 as one of the important steps in expanding patients' access to life-saving treatments; An action that has been carried out with the aim of reducing inequality in access to transplantation and increasing the opportunity for treatment of children in need.

Professor of Tehran University of Medical Sciences emphasized on justice in treating children's cancer

In his speech, this faculty member of Tehran University of Medical Sciences considered receiving the global award a common honor for doctors, nurses, researchers, students and all those involved in the treatment of children's cancer, and dedicated it to children whose fight against the disease has inspired scientific and therapeutic efforts.

Hamidiyeh also emphasized the need to strengthen regional cooperation in the fight against cancer, and called for the development of knowledge exchange, scientific data, joint research and fair access to new treatment technologies.

He listed the use of advanced technologies, including CAR-T cells, CRISPR gene editing technology, and mRNA-based methods as important future opportunities for cancer treatment, and emphasized the need for children and adults in the Eastern Mediterranean region to benefit from these developments.